Sorrento Therapeutics to Present Potential "Game-Changer" Non-Viral CAR-T Technology for Autologous and Allogeneic (off-the-shelf) CAR-T Therapies

Stock Information for Sorrento Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.